0001209191-22-024317.txt : 20220413
0001209191-22-024317.hdr.sgml : 20220413
20220413171813
ACCESSION NUMBER: 0001209191-22-024317
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220412
FILED AS OF DATE: 20220413
DATE AS OF CHANGE: 20220413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spence Padraic L.
CENTRAL INDEX KEY: 0001462709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40630
FILM NUMBER: 22825399
MAIL ADDRESS:
STREET 1: C/O PHYSICIANS FORMULA HOLDINGS, INC.
STREET 2: 1055 WEST 8TH STREET
CITY: AZUSA
STATE: CA
ZIP: 91702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zevia PBC
CENTRAL INDEX KEY: 0001854139
STANDARD INDUSTRIAL CLASSIFICATION: BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS [2086]
IRS NUMBER: 862862492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15821 VENTURA BLVD.
STREET 2: SUITE 145
CITY: ENCINO
STATE: CA
ZIP: 91436
BUSINESS PHONE: (310) 202-7000
MAIL ADDRESS:
STREET 1: 15821 VENTURA BLVD.
STREET 2: SUITE 145
CITY: ENCINO
STATE: CA
ZIP: 91436
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-12
0
0001854139
Zevia PBC
ZVIA
0001462709
Spence Padraic L.
C/O ZEVIA PBC
15821 VENTURA BLVD., SUITE 145
ENCINO
CA
91436
1
1
0
0
Chair, Chief Executive Officer
Class A Common Stock
2022-04-12
4
S
0
34045
4.043
D
2559536
D
The transaction reported reflects the sale of shares of Class A Common Stock in satisfaction of the Reporting Person's tax liability in connection with the settlement of 61,111 restricted stock units ("RSUs"). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade made by the Reporting Person.
The price reported in Column 4 is a weighted average sale price of the Issuer's Class A Common Stock. These shares were sold in multiple transactions at prices ranging from $3.80 to $4.31, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 2,426,194 RSUs. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer. 2,200,000 RSUs began vesting in 1/36 equal monthly installments on each monthly anniversary of January 17, 2022 and are settled within 30 days following each vesting date. 200,000 RSUs are vested in full, subject to deferred settlement in 1/3 increments on each of January 17, 2023, January 17, 2024, and January 17, 2025. 148,417 RSUs begin vesting in 1/4 increments on each anniversary of March 17, 2022 and are settled within 30 days following each vesting date.
/s/ Lorna R. Simms, Attorney-in-Fact for Padraic L. Spence
2022-04-13